Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.815 USD | +1.62% | -1.05% | -31.17% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 367M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.78 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.72 x |
P/E ratio 2024 * |
-277
x | P/E ratio 2025 * |
51.9
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | +1.09% | ||
1 week | -6.42% | ||
Current month | +17.87% | ||
1 month | -4.48% | ||
3 months | -19.01% | ||
6 months | +5.73% | ||
Current year | -32.27% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -1.40% | - | |
0.09% | 28 M€ | -0.70% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 2.815 | +1.62% | 111 220 |
24-05-20 | 2.77 | +1.09% | 385,433 |
24-05-17 | 2.74 | -3.86% | 483,387 |
24-05-16 | 2.85 | -4.04% | 554,237 |
24-05-15 | 2.97 | +4.39% | 579,261 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.27% | 367M | |
+41.79% | 54.04B | |
-0.56% | 41.92B | |
+49.62% | 41.96B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+24.91% | 12.19B | |
+29.60% | 12.28B |
- Stock Market
- Equities
- ORGO Stock